🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementI literally cannot eat more than 3 bites help — anyone have experience?

I literally cannot eat more than 3 bites help — anyone have experience?

Dr.DermMIA Fri, Oct 18, 2024 at 6:24 PM 37 replies 2,114 viewsPage 1 of 8
This thread is more than 19 months old. Information may be outdated. Consider searching for more recent discussions.
Dr.DermMIA
Member
456
2,123
May 2024
Miami, FL
Oct 18, 2024 at 6:24 PM#1

This gets cited here weekly, usually second-hand, so it is worth setting out what it does and does not establish.

Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts. Receptor-level tachyphylaxis to the delayed-emptying effect develops over weeks while the central appetite effect persists, so the same dose is materially more comfortable at week six than at week two. A slower ladder therefore reaches the same dose with less cumulative nausea, not the same nausea spread thinner.

Where I think it is weakest: the follow-up is short relative to how long people actually take these drugs, so durability is an assumption here rather than a finding.

The bit I cannot resolve on my own is what distinguishes the nausea you can titrate through from the nausea that means stop. If the honest answer is that nobody knows, that is a useful answer and I would rather have it.

Note on sourcing:
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
1 21LipidDoc_ATL
Reply Quote Save Share Report
DataDave
Senior Member
1,678
8,901
Apr 2024
Washington
Online
Oct 18, 2024 at 7:06 PM#2
Dr.DermMIA said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

That is correct as far as it goes, and here is where it stops going. The line between titrate-through and stop is not severity, it is trajectory and what else is present. Nausea that peaks and improves within a week is the expected pattern. Nausea that is escalating, or that comes with severe upper-abdominal pain radiating to the back, or that prevents fluids for more than a day, is a different conversation and belongs with a clinician the same day.

Last edited: Oct 18, 2024 at 8:06 PM
50 20mike_nyc, VendorMark, COA_Karl and 47 others
Reply Quote Save Share Report
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Oct 18, 2024 at 7:48 PM#3
Dr.DermMIA said:
Holding genuinely reduces total burden rather than redistributing it, because the gastric-emptying component adapts.

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

49 19tampaLisa73, KarenAZ_mom, zoe_NC and 46 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
julia.endo
Senior Member
1,890
9,012
Feb 2024
Cincinnati, OH
Oct 18, 2024 at 8:30 PM#4

Taking the question as asked, rather than the general version of it. The practical protocol is dull and it works: smaller meals, stop eating at the first sign of fullness rather than at the end of the plate, drop the fat fraction of meals in the two days after dosing, and do not lie down straight after eating. Most of what people call unmanageable nausea is a meal-size and meal-composition problem interacting with a stomach that is emptying slowly.

Last edited: Oct 19, 2024 at 2:30 AM
48 18jason_sac26, chris_chi24, tampaLisa73 and 45 others
Reply Quote Save Share Report
TomTeleRx
Member
189
678
Feb 2025
Delaware
Oct 19, 2024 at 12:24 AM#5
DataDave said:
The line between titrate-through and stop is not severity, it is trajectory and what else is present.

Can confirm. Same sequence, different timescale. Posting only so the count is not one.

Last edited: Oct 19, 2024 at 1:24 AM
47 17TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 44 others
Reply Quote Save Share Report
1238

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register